Also known as: Nexavar; BAY 43-9006
Sorafenib is an oral multikinase inhibitor that targets multiple receptor tyrosine kinases (VEGFR, PDGFR) and Raf kinases. It is used in the treatment of hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid cancer. Mediocon Inc manufactures GMP-compliant Sorafenib API at its Aurangabad facility to international pharmacopoeial standards.
| Parameter | Specification |
|---|---|
| CAS Number | 284461-73-0 |
| Molecular Formula | C₂₁H₁₆ClF₃N₄O₃ |
| Molecular Weight | 464.83 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Anticancer / Kinase Inhibitor |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | SF/25030252 |
| Mfg Date | MAR 2025 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Sorafenib — CAS 284461-73-0 (CAS 284461-73-0) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Sorafenib — CAS 284461-73-0 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance